Delivery Order SPE2DB22D3016-SPE2DB24FAWM5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,640.84 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% Eye Drops, 5 ml, with a completion date of July 25, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award, valued at $1,097.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of LOTEPREDNOL ETABONATE 0.2% DRP 5ML, a pharmaceutical eye drop product. The contract has an ultimate completion date of December 24, 2024 and is a firm fixed-price contract. AmerisourceBergen, a for-profit organization, is the prime contractor,...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,240.45 firm fixed-price contract is for the delivery of Loteprednol Etabonate 0.5% ophthalmic drops. The order has a completion date of June 23, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $1,405.28 firm-fixed-price delivery order is for the supply of 4558884048 - Loteprednol Etabonate 0.5% Eye Drops in 5 mL containers. The contract has an ultimate completion date of October 26, 2022 and was awarded on October 25, 2022. This contract is not designated as a set-aside. Amerisourcebergen holds a...
- The Defense Logistics Agency (DLA) awarded a $9,971.22 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of loteprednol etabonate 0.5% eye drops. This delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,672.09, is for the delivery of Loteprednol Etabonate 0.5% eye drops. The contract is a firm fixed-price delivery order with a completion date of December 19, 2022. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,102.82 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% ophthalmic drops (5ml). The contract was awarded on September 7, 2021, with a completion date of September 8, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and is registered in the System...
- This is a $1,866.34 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of loteprednol etabonate 0.5% eye drops, a prescription medication, and has an ultimate completion date of September 20, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with DLA and the Department of Justice Federal Bureau of Investigation for providing a wide range of...
- The Defense Logistics Agency awarded a $1,842.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in 5 mL quantities. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is non-competitive and scheduled for completion by August 1, 2025. Performance will be fulfilled...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,449.86 Firm Fixed Price Delivery Order is for the supply of 4,564,730,207 units of Loteprednol Etabonate 0.5% ophthalmic drops, with a performance period ending on May 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a Single-Award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAWM5Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.07 firm fixed-price delivery order is for the supply of loteprednol etabonate 0.5% eye drops, a medication used for the treatment of various eye conditions. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order appears to be one of many individual orders placed against that larger IDC contract. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 5/23/24 |